142 related articles for article (PubMed ID: 19309495)
21. Use of taurolidine in lung transplantation for cystic fibrosis and impact on bacterial colonization.
Zeriouh M; Sabashnikov A; Patil NP; Schmack B; Zych B; Mohite PN; García Sáez D; Koch A; Mansur A; Soresi S; Weymann A; Marczin N; Wahlers T; De Robertis F; Simon AR; Popov AF
Eur J Cardiothorac Surg; 2018 Mar; 53(3):603-609. PubMed ID: 29048473
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection.
Bauhofer A; Stinner B; Kohlert F; Reckzeh B; Lorenz W; Celik I
Br J Surg; 2002 Nov; 89(11):1457-64. PubMed ID: 12390392
[TBL] [Abstract][Full Text] [Related]
23. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
24. Taurolidine inhibits tumor cell growth in vitro and in vivo.
McCourt M; Wang JH; Sookhai S; Redmond HP
Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
[TBL] [Abstract][Full Text] [Related]
25. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
[TBL] [Abstract][Full Text] [Related]
26. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
27. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery.
Hovenden JL; Phillips G
Br J Surg; 1995 Feb; 82(2):280. PubMed ID: 7749714
[No Abstract] [Full Text] [Related]
28. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Jacobi CA; Ordemann J; Böhm B; Zieren HU; Sabat R; Müller JM
Am J Surg; 1997 Sep; 174(3):359-63. PubMed ID: 9324156
[TBL] [Abstract][Full Text] [Related]
29. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
Klek S; Szczepanek K; Hermanowicz A; Galas A
JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
[TBL] [Abstract][Full Text] [Related]
30. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery.
Reding R; Pfirrman RW
Br J Surg; 1995 Apr; 82(4):569. PubMed ID: 7613917
[No Abstract] [Full Text] [Related]
31. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
32. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
[TBL] [Abstract][Full Text] [Related]
33. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Bhargava R; Mitsides N; Heap M; Green G; Diggle P
Semin Dial; 2012; 25(2):233-8. PubMed ID: 21916999
[TBL] [Abstract][Full Text] [Related]
34. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
35. Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.
Klimek K; Aresté Fosalba N; Ramírez López MÁ; Gómez Castilla AC; Salgueira Lazo M
Nefrologia (Engl Ed); 2020; 40(2):197-201. PubMed ID: 31208832
[TBL] [Abstract][Full Text] [Related]
36. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Chu HP; Brind J; Tomar R; Hill S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
[TBL] [Abstract][Full Text] [Related]
37. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
38. The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.
Imhof L; Goldinger SM; Baumann K; Schad K; French LE; Röthlisberger P; Dummer R
Melanoma Res; 2011 Feb; 21(1):80-3. PubMed ID: 21052029
[TBL] [Abstract][Full Text] [Related]
39. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
[TBL] [Abstract][Full Text] [Related]
40. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
